4//SEC Filing
WEAVER GREGORY L 4
Accession 0001437749-23-017896
CIK 0001488039other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:15 PM ET
Size
5.0 KB
Accession
0001437749-23-017896
Insider Transaction Report
Form 4
WEAVER GREGORY L
Director
Transactions
- Purchase
Common Stock
2023-06-20$0.97/sh+50,000$48,500→ 50,055 total
Footnotes (2)
- [F1]The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
- [F2]Includes shares of common stock purchased on November 21, 2013, which were previously reported on a Form 4 filed by the Reporting Person on November 22, 2013 but erroneously omitted in subsequent filings.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001251779
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 8:15 PM ET
- Size
- 5.0 KB